Moreover, AURKA mRNA was significantly over-expressed in poor (grade III) or moderately differentiated (grade II) lung cancer specimens compared to well-differentiated cases (grade I) (Figure.2, panel B, p < 0.01). This evidence concerns the gene AURKA and lung carcinoma.